[go: up one dir, main page]

AU1801195A - Antigenic preparation for treatment or prevention of helicobacter infection - Google Patents

Antigenic preparation for treatment or prevention of helicobacter infection

Info

Publication number
AU1801195A
AU1801195A AU18011/95A AU1801195A AU1801195A AU 1801195 A AU1801195 A AU 1801195A AU 18011/95 A AU18011/95 A AU 18011/95A AU 1801195 A AU1801195 A AU 1801195A AU 1801195 A AU1801195 A AU 1801195A
Authority
AU
Australia
Prior art keywords
prevention
treatment
antigenic preparation
helicobacter infection
helicobacter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU18011/95A
Other versions
AU693864B2 (en
Inventor
Ian George Barr
Fiona Jane Buck
Christopher Vincent Doidge
Michael John Kleinig
Adrian Lee
Elizabeth Pietrzykowski
Charles Alexander Quinn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
UNSW Sydney
Original Assignee
CSL Ltd
UNSW Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Ltd, UNSW Sydney filed Critical CSL Ltd
Priority to AU18011/95A priority Critical patent/AU693864B2/en
Publication of AU1801195A publication Critical patent/AU1801195A/en
Application granted granted Critical
Publication of AU693864B2 publication Critical patent/AU693864B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

An antigenic preparation for use in the treatment or prevention of Helicobacter infection in a mammalian host, comprises the lipopolysaccharide (LPS) of Helicobacter bacteria, particularly the LPS of H. pylori or H. felis, or an immunogenic fragment thereof.
AU18011/95A 1994-02-21 1995-02-17 Antigenic preparation for treatment or prevention of helicobacter infection Ceased AU693864B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU18011/95A AU693864B2 (en) 1994-02-21 1995-02-17 Antigenic preparation for treatment or prevention of helicobacter infection

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPM3995A AUPM399594A0 (en) 1994-02-21 1994-02-21 Antigenic preparation for treatment or prevention of helicobacter infection
AUPM3995 1994-02-21
AU18011/95A AU693864B2 (en) 1994-02-21 1995-02-17 Antigenic preparation for treatment or prevention of helicobacter infection
PCT/AU1995/000077 WO1995022563A1 (en) 1994-02-21 1995-02-17 Antigenic preparation for treatment or prevention of helicobacter infection

Publications (2)

Publication Number Publication Date
AU1801195A true AU1801195A (en) 1995-09-04
AU693864B2 AU693864B2 (en) 1998-07-09

Family

ID=3778612

Family Applications (2)

Application Number Title Priority Date Filing Date
AUPM3995A Abandoned AUPM399594A0 (en) 1994-02-21 1994-02-21 Antigenic preparation for treatment or prevention of helicobacter infection
AU18011/95A Ceased AU693864B2 (en) 1994-02-21 1995-02-17 Antigenic preparation for treatment or prevention of helicobacter infection

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AUPM3995A Abandoned AUPM399594A0 (en) 1994-02-21 1994-02-21 Antigenic preparation for treatment or prevention of helicobacter infection

Country Status (11)

Country Link
US (1) US6663873B2 (en)
EP (1) EP0804489B1 (en)
JP (1) JPH10500102A (en)
KR (1) KR100351534B1 (en)
AT (1) ATE222930T1 (en)
AU (2) AUPM399594A0 (en)
CA (1) CA2182274C (en)
DE (1) DE69527986T2 (en)
HK (1) HK1004677A1 (en)
NZ (2) NZ281146A (en)
WO (1) WO1995022563A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996033220A1 (en) * 1995-04-21 1996-10-24 Csl Limited Protective helicobacter antigens
AU693679B2 (en) * 1995-04-21 1998-07-02 Csl Limited Protective helicobacter antigens

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM399594A0 (en) * 1994-02-21 1994-03-17 Csl Limited Antigenic preparation for treatment or prevention of helicobacter infection
CZ104297A3 (en) * 1994-10-05 1997-11-12 Microcarb Methods of producing higher antigenic heliobacter spp. and vaccines containing thereof
US5679564A (en) * 1994-10-05 1997-10-21 Antex Biologics, Inc. Methods for producing enhanced antigenic campylobacter bacteria and vaccines
WO1998042189A1 (en) * 1997-03-26 1998-10-01 Avant Immunotherapeutics, Inc. POLYPEPTIDES WHICH IMMUNOREACT WITH POLYCLONAL ANTISERA AGAINST $i(H. PYLORI)
GB9715702D0 (en) * 1997-07-24 1997-10-01 Univ Bristol Bacterial isolate
US6599509B2 (en) 1997-09-02 2003-07-29 Massachusetts Institute Of Technology Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease
WO2002066631A1 (en) * 2001-02-21 2002-08-29 Denka Seiken Co., Ltd. Antibodies recognizing helicobacter pylori and method of detecting helicobacter pylori
DE102004024674A1 (en) * 2004-05-18 2005-12-15 Wolfgang Lorenz Means and methods for the diagnosis, prophylaxis and therapy of connective tissue diseases
EP1930025B1 (en) 2005-08-05 2013-05-01 The University of Tokushima ANTIGEN-AND-DRUG VEHICLE WHICH ENABLES THE CHANGEOVER FROM THE SELECTIVE PRODUCTION OF IgA ANTIBODY TO THE PRODUCTION OF BOTH OF IgA AND IgG ANTIBODIES, AND TRANSNASAL/TRANSMUCOSAL VACCINE USING THE VEHICLE
PL2945651T3 (en) 2013-01-17 2018-08-31 Arsanis Biosciences Gmbh Mdr e. coli specific antibody
CN106536551B (en) 2014-02-06 2021-04-16 X4制药(奥地利)有限责任公司 Specific antibody sequence of Escherichia coli
CN106535927B (en) 2014-02-24 2019-09-20 葛兰素史密丝克莱恩生物有限公司 Novel polysaccharide and application thereof
TWI715617B (en) 2015-08-24 2021-01-11 比利時商葛蘭素史密斯克藍生物品公司 Methods and compositions for immune protection against extra-intestinal pathogenic e. coli
AR109621A1 (en) 2016-10-24 2018-12-26 Janssen Pharmaceuticals Inc FORMULATIONS OF VACCINES AGAINST GLUCOCONJUGADOS OF EXPEC
WO2020191082A1 (en) 2019-03-18 2020-09-24 Janssen Pharmaceuticals, Inc. Bioconjugates of e. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereof
CA3134045A1 (en) 2019-03-18 2020-09-24 Janssen Pharmaceuticals, Inc. Methods of producing bioconjugates of e. coli o-antigen polysaccharides, compositions thereof, and methods of use thereof
CN111467368B (en) * 2020-04-13 2021-05-28 江南大学 Application of oligosaccharide compound containing heptose chain in preparation of Helicobacter pylori vaccine
JP7481585B2 (en) 2020-09-17 2024-05-10 ヤンセン ファーマシューティカルズ，インコーポレーテッド Multivalent vaccine compositions and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU644121B2 (en) 1989-12-04 1993-12-02 Auspharm International Limited Rapid in vitro test for helicobacter pylori using saliva
US5217872A (en) * 1990-02-27 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Method for detection of borrelia burgdorferi antigens
US5098755A (en) * 1990-11-21 1992-03-24 Tanquary Albert C Textured thermoplastic elastomeric film, articles comprising same, and method of making such textured thermoplastic elastomeric film and articles
MX9301706A (en) 1992-04-13 1994-05-31 Oravax Inc VACCINE COMPOSITION FOR THE TREATMENT OF HELICOBACTER INFECTION.
WO1993022343A1 (en) * 1992-05-01 1993-11-11 The Rockfeller University Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom
US6258359B1 (en) * 1993-05-19 2001-07-10 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
US6406703B1 (en) * 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
ATE244578T1 (en) * 1993-07-27 2003-07-15 Csl Ltd TREATMENT OF GASTRODUODENAL DISEASE CAUSED BY HELICOBACTER
JPH09511220A (en) * 1993-11-10 1997-11-11 ブリストル‐マイヤーズ スクイブ カンパニー Treatment of inflammatory diseases induced by bacteria
AUPM399594A0 (en) * 1994-02-21 1994-03-17 Csl Limited Antigenic preparation for treatment or prevention of helicobacter infection
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
US5679564A (en) * 1994-10-05 1997-10-21 Antex Biologics, Inc. Methods for producing enhanced antigenic campylobacter bacteria and vaccines
EP0821698A4 (en) * 1995-04-21 2005-06-29 Csl Ltd PROTECTIVE HELIOBACTER ANTIGENES
US5997881A (en) * 1995-11-22 1999-12-07 University Of Maryland, Baltimore Method of making non-pyrogenic lipopolysaccharide or A
AU3458299A (en) * 1998-03-31 1999-10-18 United States Of America, As Represented By The Secretary Of Agriculture, The Monoclonal antibodies against (campylobacter jejuni) and (campylobacter coli) outer membrane antigens
US6576244B1 (en) * 1998-06-19 2003-06-10 Acambis, Inc. LT and CT in parenteral immunization methods against helicobacter infection

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996033220A1 (en) * 1995-04-21 1996-10-24 Csl Limited Protective helicobacter antigens
AU693679B2 (en) * 1995-04-21 1998-07-02 Csl Limited Protective helicobacter antigens

Also Published As

Publication number Publication date
CA2182274C (en) 2007-05-22
NZ281146A (en) 1998-04-27
EP0804489A1 (en) 1997-11-05
CA2182274A1 (en) 1995-08-24
DE69527986T2 (en) 2003-04-10
KR100351534B1 (en) 2003-03-15
EP0804489B1 (en) 2002-08-28
KR970701209A (en) 1997-03-17
AU693864B2 (en) 1998-07-09
HK1004677A1 (en) 1998-12-04
JPH10500102A (en) 1998-01-06
US6663873B2 (en) 2003-12-16
WO1995022563A1 (en) 1995-08-24
DE69527986D1 (en) 2002-10-02
ATE222930T1 (en) 2002-09-15
EP0804489A4 (en) 1997-11-19
US20020122794A1 (en) 2002-09-05
NZ329879A (en) 1999-10-28
AUPM399594A0 (en) 1994-03-17

Similar Documents

Publication Publication Date Title
AUPM399594A0 (en) Antigenic preparation for treatment or prevention of helicobacter infection
AUPM612494A0 (en) Treatment or prevention of helicobacter infection
AU1199900A (en) Use of purified invaplex from gram negative bacteria as a vaccine
GB2303854B (en) Helicobacter proteins and vaccines
GB2322801A (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
AU1234697A (en) Streptococcus equi vaccine
HK1005541A1 (en) Treatment of helicobacter associated gastroduodenal disease
AU3580800A (en) Method of and compositions for immunization with the (pseudomonas) v antigen
AU2238597A (en) Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen
AU3853495A (en) Immunogenic compositions
AU637146B2 (en) Parking-brake operating device
NZ335050A (en) Helicobacter pylori live vaccine
WO2000050073A3 (en) Caulobacter lps immunoadjuvant
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
NZ332809A (en) Immunogenic complex comprising a oligo- or polysaccharide epitope and a carrier protein with a portion of an OmpA-type outer membrane protein of a bacterial and vaccines of such complexes containing same
AU4672896A (en) Helicobacter pylori antigen
AU5091898A (en) Method of vaccinating infants against infections
CA2191440A1 (en) Treatment and prevention of helicobacter infection
GB9018061D0 (en) Compositions for vaccines
AU1825895A (en) Retroviral vaccines, vaccination and immune-therapy for retroviral infections
NZ331674A (en) Use of antigenic preparations comprising Helicobacter catalase for treating or preventing Helicobacter infection
MX9700215A (en) Helicobacter proteins and vaccines.
MX9708226A (en) Vaccines containing a saponin and a sterol.